Total Payments
$886.52
2024 Payments
$63.24
Companies
15
Transactions
38
Medicare Patients
682
Medicare Billing
$39,805
Payment Breakdown by Category
Food & Beverage$846.53 (95.5%)
Education$39.99 (4.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $846.53 | 37 | 95.5% |
| Education | $39.99 | 1 | 4.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bausch & Lomb, a division of Bausch Health US, LLC | $271.83 | 11 | $0 (2021) |
| Shire North American Group Inc | $216.47 | 4 | $0 (2018) |
| Allergan, Inc. | $63.75 | 4 | $0 (2022) |
| Omeros Corporation | $54.51 | 3 | $0 (2019) |
| Sun Pharmaceutical Industries Inc. | $51.95 | 2 | $0 (2019) |
| Kala Pharmaceuticals, Inc. | $40.37 | 2 | $0 (2021) |
| ABBVIE INC. | $40.27 | 2 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $39.68 | 3 | $0 (2020) |
| Biogen, Inc. | $22.86 | 1 | $0 (2024) |
| Myriad Genetic Laboratories, Inc. | $18.15 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $63.24 | 3 | Biogen, Inc. ($22.86) |
| 2023 | $18.04 | 1 | AbbVie Inc. ($18.04) |
| 2022 | $17.66 | 1 | Allergan, Inc. ($17.66) |
| 2021 | $58.04 | 3 | Bausch & Lomb, a division of Bausch Health US, LLC ($23.73) |
| 2020 | $72.10 | 4 | Bausch & Lomb, a division of Bausch Health US, LLC ($57.52) |
| 2019 | $174.11 | 10 | Sun Pharmaceutical Industries Inc. ($51.95) |
| 2018 | $235.98 | 10 | Bausch & Lomb, a division of Bausch Health US, LLC ($143.67) |
| 2017 | $247.35 | 6 | Shire North American Group Inc ($196.19) |
All Payment Transactions
38 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/12/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: ONCOLOGY | ||||||
| 04/11/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $22.23 | General |
| Category: EYE CARE | ||||||
| 02/07/2024 | Biogen, Inc. | SPINRAZA (Biological) | Food and Beverage | In-kind items and services | $22.86 | General |
| Category: Neurology | ||||||
| 04/28/2023 | AbbVie Inc. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: EYE CARE | ||||||
| 01/21/2022 | Allergan, Inc. | VUITY (Drug) | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/10/2021 | Eyevance Pharmaceuticals LLC | Tobradex ST (Drug) | Food and Beverage | In-kind items and services | $11.65 | General |
| Category: Anti-Infective/Steroid | ||||||
| 11/03/2021 | Bausch & Lomb, a division of Bausch Health US, LLC | VYZULTA (Drug), BESIVANCE, ZYLET | Food and Beverage | In-kind items and services | $23.73 | General |
| Category: Ophthalmology | ||||||
| 01/13/2021 | Kala Pharmaceuticals, Inc. | INVELTYS (Drug), EYSUVIS | Food and Beverage | In-kind items and services | $22.66 | General |
| Category: Ocular | ||||||
| 10/21/2020 | Bausch & Lomb, a division of Bausch Health US, LLC | VYZULTA (Drug), ZYLET, BESIVANCE | Food and Beverage | In-kind items and services | $23.48 | General |
| Category: OPHTHALMOLOGY | ||||||
| 02/14/2020 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: OPHTHALMOLOGY | ||||||
| 02/12/2020 | Bausch & Lomb, a division of Bausch Health US, LLC | VYZULTA (Drug), BESIVANCE, ZYLET | Food and Beverage | In-kind items and services | $18.57 | General |
| Category: OPHTHALMOLOGY | ||||||
| 02/04/2020 | Bausch & Lomb, a division of Bausch Health US, LLC | LOTEMAX SM (Drug) | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/26/2019 | Bausch & Lomb, a division of Bausch Health US, LLC | LOTEMAX SM (Drug) | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/12/2019 | Bausch & Lomb, a division of Bausch Health US, LLC | VYZULTA (Drug), ZYLET, BESIVANCE | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/13/2019 | Sun Pharmaceutical Industries Inc. | — | Education | In-kind items and services | $39.99 | General |
| 10/03/2019 | Allergan Inc. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/29/2019 | Omeros Corporation | Omidria (Drug) | Food and Beverage | Cash or cash equivalent | $17.52 | General |
| Category: Ophthalmology | ||||||
| 08/28/2019 | Bausch & Lomb, a division of Bausch Health US, LLC | VYZULTA (Drug), BESIVANCE, ZYLET | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/23/2019 | EyePoint Pharmaceuticals US, Inc. | DEXYCU (Drug) | Food and Beverage | In-kind items and services | $11.75 | General |
| Category: Postoperative Inflammation | ||||||
| 03/28/2019 | Novartis Pharmaceuticals Corporation | TRAVATAN Z (Drug) | Food and Beverage | In-kind items and services | $12.56 | General |
| Category: OPHTHALMOLOGY | ||||||
| 02/01/2019 | Kala Pharmaceuticals, Inc. | INVELTYS (Drug) | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: OCULAR | ||||||
| 01/31/2019 | Sun Pharmaceutical Industries Inc. | XELPROS (Drug) | Food and Beverage | Cash or cash equivalent | $11.96 | General |
| Category: Ophthalmology | ||||||
| 12/10/2018 | Allergan Inc. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/19/2018 | Bausch & Lomb, a division of Bausch Health US, LLC | BESIVANCE (Drug), VYZULTA | Food and Beverage | In-kind items and services | $15.46 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/27/2018 | Novartis Pharmaceuticals Corporation | TRAVATAN Z (Drug) | Food and Beverage | In-kind items and services | $12.54 | General |
| Category: OPHTHALMOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 3 | 67 | 67 | $8,770 | $3,503 |
| 2021 | 5 | 176 | 183 | $25,740 | $10,672 |
| 2020 | 9 | 439 | 484 | $56,998 | $25,631 |
Total Patients
682
Total Services
734
Medicare Billing
$39,805
Procedure Codes
17
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92014 | Established patient complete exam of visual system | Office | 2022 | 27 | 27 | $4,050 | $1,876 | 46.3% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 14 | 14 | $1,470 | $1,021 | 69.4% |
| 92250 | Photography of the retina | Office | 2022 | 26 | 26 | $3,250 | $606.07 | 18.6% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 50 | 50 | $7,500 | $4,114 | 54.9% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2021 | 39 | 46 | $4,830 | $2,793 | 57.8% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Office | 2021 | 27 | 27 | $4,860 | $2,148 | 44.2% |
| 92250 | Photography of the retina | Office | 2021 | 46 | 46 | $5,750 | $1,119 | 19.5% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2021 | 14 | 14 | $2,800 | $497.53 | 17.8% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2020 | 138 | 139 | $21,310 | $10,886 | 51.1% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2020 | 96 | 108 | $12,250 | $5,458 | 44.6% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Office | 2020 | 30 | 30 | $5,470 | $2,851 | 52.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 33 | 33 | $4,125 | $1,938 | 47.0% |
| 92250 | Photography of the retina | Office | 2020 | 57 | 57 | $7,185 | $1,876 | 26.1% |
| 83861 | Microfluid analysis of tears | Office | 2020 | 30 | 60 | $1,550 | $1,330 | 85.8% |
| 92083 | Measurement of field of vision during daylight conditions | Office | 2020 | 23 | 24 | $2,910 | $725.47 | 24.9% |
| 92020 | Examination of cornea and iris using lens device and slit lamp | Office | 2020 | 15 | 15 | $773.00 | $317.13 | 41.0% |
| 92133 | Diagnostic imaging of optic nerve of eye | Office | 2020 | 17 | 18 | $1,425 | $249.69 | 17.5% |
About Dr. Amy Smith, MD
Dr. Amy Smith, MD is a Ophthalmology healthcare provider based in Pontiac, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/01/2005. The National Provider Identifier (NPI) number assigned to this provider is 1255333514.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Amy Smith, MD has received a total of $886.52 in payments from pharmaceutical and medical device companies, with $63.24 received in 2024. These payments were reported across 38 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($846.53).
As a Medicare-enrolled provider, Smith has provided services to 682 Medicare beneficiaries, totaling 734 services with total Medicare billing of $39,805. Data is available for 3 years (2020–2022), covering 17 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Location Pontiac, MI
- Active Since 06/01/2005
- Last Updated 09/16/2022
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1255333514
Products in Payments
- XIIDRA (Drug) $231.05
- VYZULTA (Drug) $203.60
- Omidria (Drug) $54.51
- BESIVANCE (Drug) $46.37
- INVELTYS (Drug) $40.37
- DURYSTA (Drug) $40.27
- LUMIGAN (Drug) $29.37
- LOTEMAX SM (Drug) $28.62
- TRAVATAN Z (Drug) $25.10
- SPINRAZA (Biological) $22.86
- PROLARIS (Device) $18.15
- VUITY (Drug) $17.66
- RESTASIS (Drug) $16.72
- Cosopt PF (Drug) $14.79
- XELPROS (Drug) $11.96
- DEXYCU (Drug) $11.75
- Tobradex ST (Drug) $11.65
- CyPass (Device) $11.14
- ALREX (Drug) $10.59
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.